Government seeks deal for RSV vaccine


NIP-funded RSV vaccine for women in late-stage pregnancy on the horizon  Talks between the government and Pfizer to deliver a National Immunisation Program (NIP) funded respiratory syncytial virus (RSV) vaccine for women in late-stage pregnancy are close to a conclusion, Mark Butler the Minister for Health and Aged Care says.  Speaking at a press conference

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Bridging the theory-practice gap: patient perspectives
Next ‘Pharmacists are uniquely positioned to influence public health’